UB Paderborn / Katalog / Suche / in CDI

Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers

Cancers, 2020, Vol.12 (4), p.902

2020

Volltextzugriff (PDF)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19

International journal of molecular sciences, 2020-05, Vol.21 (10), p.3492

2020

Volltextzugriff (PDF)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

International journal of molecular sciences, 2019-01, Vol.20 (1), p.229

2019

Volltextzugriff (PDF)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4750

2021

Volltextzugriff (PDF)

Abstract A41: Ovarian cancer as an infectious disease. Targeting of mitochondrial activity to prevent and treat recurrent ovarian cancer

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A41-A41

Bazzaro, Martina

2018

Volltextzugriff (PDF)

Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling Nanotubes

Frontiers in cell and developmental biology, 2018-10, Vol.6, p.95-95

2018

Volltextzugriff (PDF)

Targeting Deubiquitinating Enzymes and Autophagy in Cancer

Methods in molecular biology (Clifton, N.J.), 2017-01, Vol.1513, p.49

2017

Volltextzugriff (PDF)

The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol

The Journal of biological chemistry, 2023-11, Vol.299 (11), p.105355, Article 105355

2023

Volltextzugriff (PDF)

UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin II

Journal of cell science, 2021-01, Vol.134 (1)

2021

Volltextzugriff (PDF)

UNC-45A Breaks MT Lattice Independent of its Effect on Non-Muscle Myosin II

Journal of cell science, 2020-01

2020

Volltextzugriff (PDF)

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs

Cancer biology & therapy, 2019-10, Vol.20 (10), p.1304-1313

2019

Volltextzugriff (PDF)

UNC-45A is required for neurite extension via controlling NMII activation

Molecular biology of the cell, 2017-05, Vol.28 (10), p.1337-1346

2017

Volltextzugriff (PDF)

Abstract POSTER-THER-1405: Targeting proteasome-associated deubiquitinating enzymes for ovarian cancer treatment

Clinical cancer research, 2015-08, Vol.21 (16_Supplement), p.POSTER-THER-1405-POSTER-THER-1405

2015

Volltextzugriff (PDF)

Abstract B59: Single-cell sequencing as a prognostic and predictive tool for ovarian cancer therapy

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.B59-B59

2018

Volltextzugriff (PDF)

Abstract 5402: Single cell sequencing of high grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5402-5402

2017

Volltextzugriff (PDF)

Corrigendum to “Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells” [Gyncol. Oncol. 144 (2017) 598–606]

Gynecologic oncology, 2018-10, Vol.151 (1), p.182-186

2018

Volltextzugriff (PDF)

Abstract LB-258: Small-molecule inhibitors of de-ubiquitinating enzymes for cervical cancer treatment

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.LB-258-LB-258

2011

Volltextzugriff (PDF)

Method for measuring the activity of deubiquitinating enzymes in cell lines and tissue samples

Journal of visualized experiments, 2015-05 (99), p.e52784-e52784

2015

Volltextzugriff (PDF)

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Journal of visualized experiments, 2015-05 (99)

2015

Volltextzugriff (PDF)

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

Journal of visualized experiments, 2014-02 (84)

2014

Volltextzugriff (PDF)

Combination of proteasome and HDAC inhibitors for therapy of uterine cervical cancer

Clinical cancer research, 2009-01, Vol.15 (2), p.570-577

2009

Volltextzugriff (PDF)

Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8

Immunology, 2002-07, Vol.106 (3), p.395-403

2002

Volltextzugriff (PDF)

Synthesis and activity of N-Benzyl pseudopeptides HIV protease inhibitors

Bioorganic & medicinal chemistry, 2003-05, Vol.11 (11), p.2477-2483

2003

Volltextzugriff (PDF)

HIV-1 protease inhibitors containing an N-Hydroxyamino acid core structure

Bioorganic & medicinal chemistry, 2001-04, Vol.9 (4), p.939-945

2001

Volltextzugriff (PDF)

Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues

Bioorganic & medicinal chemistry, 2002-09, Vol.10 (9), p.3061-3066

2002

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

Abstract A41: Ovarian cancer as an infectious disease. Targeting of mitochondrial activity to prevent and treat recurrent ovarian cancer

Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling Nanotubes

Targeting Deubiquitinating Enzymes and Autophagy in Cancer

The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol

UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin II

UNC-45A Breaks MT Lattice Independent of its Effect on Non-Muscle Myosin II

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs

UNC-45A is required for neurite extension via controlling NMII activation

Abstract POSTER-THER-1405: Targeting proteasome-associated deubiquitinating enzymes for ovarian cancer treatment

Abstract B59: Single-cell sequencing as a prognostic and predictive tool for ovarian cancer therapy

Abstract 5402: Single cell sequencing of high grade serous ovarian cancer

Corrigendum to “Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells” [Gyncol. Oncol. 144 (2017) 598–606]

Abstract LB-258: Small-molecule inhibitors of de-ubiquitinating enzymes for cervical cancer treatment

Method for measuring the activity of deubiquitinating enzymes in cell lines and tissue samples

Method for Measuring the Activity of Deubiquitinating Enzymes in Cell Lines and Tissue Samples

Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens

Combination of proteasome and HDAC inhibitors for therapy of uterine cervical cancer

Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8

Synthesis and activity of N-Benzyl pseudopeptides HIV protease inhibitors

HIV-1 protease inhibitors containing an N-Hydroxyamino acid core structure

Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues

Aktive Filter

Suchergebnisse filtern